Skye Bioscience insider sells 148,079 shares
A separate partnership, 5AM Ventures VII, L.P., reported an indirect holding of 981,269 shares on September 22, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Skye Bioscience, Inc. director and 10% owner Andrew J. Schwab reported sales of common shares held by 5AM Ventures II, L.P. and 5AM Co-Investors II, L.P., totaling 148,079 shares on September 22 and 23, 2026. The September 22 sales were reported at $1.65 per share; the September 23 sales were reported at a weighted average of $1.61 per share, with sale prices ranging from $1.60 to $1.77.
Insider Trade Summary
Net Seller: 148,079 shares
Net Sell
4 txns
Insider
Schwab Andrew J.
Role
Director, 10% Owner
Sold
148,079 shs ($240K)
Share of Position Sold
100%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F3, F1 | 114,851 | $1.61 | $185K |
| Sale | Common Stock F3, F2 | 4,528 | $1.61 | $7K |
| Sale | Common Stock F1 | 27,612 | $1.65 | $46K |
| Sale | Common Stock F2 | 1,088 | $1.65 | $2K |
| Holding | Common Stock F4 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 0 shares (Indirect, By 5AM Ventures II, L.P.);
Common Stock — 0 shares (Indirect, By 5AM Co-Investors II, L.P.);
Common Stock — 981,269 shares (Indirect, By 5AM Ventures VII, L.P.)
Holdings Before and After:
Common Stock, 142,463 to 0 shares (Indirect, By 5AM Ventures II, L.P.);
Common Stock, 5,616 to 0 shares (Indirect, By 5AM Co-Investors II, L.P.)
Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (4)
- F1. The securities are directly held by 5AM Ventures II, L.P. ("Ventures II"). 5AM Partners II, LLC ("Partners II") is the sole general partner of Ventures II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F2. The securities are directly held by 5AM Co-Investors II, L.P. ("Co-Investors II"). Partners II is the sole general partner of Co-Investors II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F3. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.60 to $1.77 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- F4. The securities are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. The Reporting Person is a managing member of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Key Figures
Shares sold across reported transactions: 148,079 shares
Shares sold: 114,851 shares
Shares sold: 4,528 shares
+3 more
6 metrics
Shares sold across reported transactions
148,079 shares
September 22 and 23, 2026
Shares sold
114,851 shares
Held by 5AM Ventures II, L.P.; September 23, 2026; reported at $1.61 per share
Shares sold
4,528 shares
Held by 5AM Co-Investors II, L.P.; September 23, 2026; reported at $1.61 per share
Shares sold
27,612 shares
Held by 5AM Ventures II, L.P.; September 22, 2026; reported at $1.65 per share
Shares sold
1,088 shares
Held by 5AM Co-Investors II, L.P.; September 22, 2026; reported at $1.65 per share
Reported indirect holding
981,269 shares
5AM Ventures VII, L.P.; September 22, 2026
Key Terms
weighted average price, beneficial ownership, pecuniary interest, shared voting and investment power, +1 more
5 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership regulatory
"disclaims beneficial ownership of such securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of his pecuniary interest therein"
sole general partner financial
"is the sole general partner of Ventures II"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Were the SKYE sales under a Rule 10b5-1 plan?
No Rule 10b5-1 plan is reported for these transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
